IM Cannabis (XCNQ:IMCC) Dividend Payout Ratio : 0.00 (As of Dec. 2023)

View and export this data going back to 1980. Start your Free Trial

What is IM Cannabis Dividend Payout Ratio?

IM Cannabis's dividend payout ratio for the months ended in Dec. 2023 was 0.00.

The historical rank and industry rank for IM Cannabis's Dividend Payout Ratio or its related term are showing as below:

XCNQ:IMCC's Dividend Payout Ratio is not ranked ^*
in the Drug Manufacturers industry.
Industry Median: 0.33
* Ranked among companies with meaningful Dividend Payout Ratio only.

As of today (2024-05-04), the Dividend Yield % of IM Cannabis is 0.00%.

IM Cannabis's Dividends per Share for the months ended in Dec. 2023 was C$0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

IM Cannabis Dividend Payout Ratio Historical Data

The historical data trend for IM Cannabis's Dividend Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

IM Cannabis Dividend Payout Ratio Chart

IM Cannabis Annual Data

Trend

Apr13

Apr14

Apr16

Apr17

Apr18

Apr19

Dec20

Dec21

Dec22

Dec23

Dividend Payout Ratio

Get a 7-Day Free Trial

IM Cannabis Quarterly Data
	Jan19	Apr19	Jul19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Dividend Payout Ratio	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of IM Cannabis's Dividend Payout Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, IM Cannabis's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

IM Cannabis's Dividend Payout Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, IM Cannabis's Dividend Payout Ratio distribution charts can be found below:

* The bar in red indicates where IM Cannabis's Dividend Payout Ratio falls into.

IM Cannabis Dividend Payout Ratio Calculation

Dividend payout ratio measures the percentage of the company's earnings paid out as dividends.

IM Cannabis's Dividend Payout Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Dividend Payout Ratio	=	Dividends per Share (A: Dec. 2023 )	/	EPS without NRI (A: Dec. 2023 )
	=	0	/	-0.703
	=	N/A

IM Cannabis's Dividend Payout Ratio for the quarter that ended in Dec. 2023 is calculated as

Dividend Payout Ratio	=	Dividends per Share (Q: Dec. 2023 )	/	EPS without NRI (Q: Dec. 2023 )
	=	0	/	-0.537
	=	N/A

IM Cannabis (XCNQ:IMCC) Dividend Payout Ratio Explanation

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

IM Cannabis Dividend Payout Ratio Related Terms

Thank you for viewing the detailed overview of IM Cannabis's Dividend Payout Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

IM Cannabis (XCNQ:IMCC) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » IM Cannabis Corp (XCNQ:IMCC) » Definitions » Dividend Payout Ratio

Comparable Companies

Traded in Other Exchanges

IMCC:USA

Address

Central District, Kibbutz Glil Yam, ISR, 4690500

Website

https://www.imcannabis.com

IM Cannabis Corp is a Canada-based international medical cannabis company. It offers government-licensed cannabis products, from generic to GMP-certified and pharmaceutical-grade, for both wholesale and retail clients. The majority of its revenues are generated from sales of medical cannabis products to customers in Israel and recreational cannabis in Canada. The remaining revenues are generated from sales of medical cannabis, as well as other products, to customers in Germany. Geographically, the majority is from Israel.